Riva Alessandro 4
4 · BeiGene, Ltd. · Filed Mar 2, 2022
Insider Transaction Report
Form 4
BeiGene, Ltd.BGNE
Riva Alessandro
Director
Transactions
- Award
Share Option (Right to Buy)
2022-02-28+22,581→ 22,581 totalExercise: $16.22Exp: 2032-02-27→ Ordinary Shares (22,581 underlying)
Footnotes (2)
- [F1]The number of securities underlying each option and the exercise price therefor are represented in ordinary shares. Each American Depositary Share represents 13 ordinary shares.
- [F2]The option shall become exercisable in full upon the earlier to occur of the first anniversary of the grant date or the date of the next annual general meeting; provided, however, that all vesting shall cease if the Reporting Person resigns from the board of directors or otherwise ceases to serve as a director, unless the board determines otherwise. Unvested securities are subject to accelerated vesting upon a change in control or certain termination events. The option was granted under the Company's Independent Director Compensation Policy, as amended.